Use of neboglamine in the treatment of toxicodependency

Details Use of neboglamine in the treatment of toxicodependency Use of neboglamine in the treatment of toxicodependency

A - Human Necessities

61

K

A61K 31/16 (2006.01) A61P 25/30 (2006.01) A61P 25/32 (2006.01) A61P 25/36 (2006.01)

Patent

CA 2624449

Use of neboglamine, (S)-4-amino-N (4, 4-dimethyl-cyclohexyl) glutamic acid (CR 2249) (CAS Registry Number 163000-63-3) , the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CNS sedatives such as opiates, barbiturates, benzodiazepines, alcohol, stimulants such as amphetamines and cocaine, and hallucinogens such as LSD, mescalin, cannabis (marijuana) or fencyclidine.

L'invention concerne l'utilisation de la néboglamine, de l'acide (S)-4-amino-N-(4,4-diméthyl-cyclohexyl)glutamique (CR 2249) (numéro de registre CAS 163000-63-3), d'un mélange racémique correspondant ou d'un sel pharmaceutiquement acceptable correspondant pour la préparation d'un médicament destiné à être utilisé dans le traitement de la toxicodépendance induite par les drogues telles que les sédatifs du SNC, et notamment les opiacés, les barbituriques, les benzodiazépines, l'alcool, les stimulants tels que les amphétamines et la cocaïne, et les hallucinogènes tels que le LSD, la mescaline, le cannabis (marijuana) ou la phencyclidine.

Affiliated with

Also associated with

Rating

Use of neboglamine in the treatment of toxicodependency does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of neboglamine in the treatment of toxicodependency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of neboglamine in the treatment of toxicodependency will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1665203